Publication
Article
Pharmacy Times
Read about the new generic products featured in August.
: Taro Pharmaceutical Industries
COMPARE TO: Tazorac (Allergan)
INDICATION: Taro has launched an AB-rated generic version of Allergan’s Tazorac (tazarotene) 0.1% topical cream. Tazorac 0.1% is indicated for the topical treatment of patients with plaque psoriasis and acne vulgaris.
DOSAGE FORM: Topical cream: 0.1%
FOR MORE INFORMATION: taro.com
EZETIMIBE TABLETSMARKETED BY: Teva Pharmaceuticals
COMPARE TO: Zetia (Merck)
INDICATION: Teva has announced the US launch of generic Zetia (ezetimibe) tablets, 10 mg. Ezetimibe tablets are indicated to lower levels of total cholesterol and low-density lipoprotein cholesterol in the blood. Ezetimibe tablets are for patients who cannot control their cholesterol levels by diet and exercise alone.
DOSAGE FORM: Tablets: 10 mg
FOR MORE INFORMATION: tevapharm.com
PERPHENAZINEMARKETED BY: Teva Pharmaceuticals
COMPARE TO: Trilafon (Merck)
INDICATION: Teva has launched its generic of Trilafon (perphenazine) tablets. The drug is indicated to treat schizophrenia and to control severe nausea and vomiting in adults. DOSAGE FORM: Tablets: 2, 4, 8, and 16 mg
FOR MORE INFORMATION: tevapharm.com
ACYCLOVIRMARKETED BY: Taro Pharmaceutical Industries
COMPARE TO: Zovirax (Valeant)
INDICATION: Taro has launched its generic of Zovirax (acyclovir) ointment, 5%. The drug is indicated in the management of initial genital herpes and in limited nonlife-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.
DOSAGE FORM: Topical: ½-inch ribbon of ointment per 4 square inches of surface area
FOR MORE INFORMATION: taro.com